In the first study, NMR solution conformations were reported for native contulakin-G with β--Galp-(1→3)-α--GalpNAc-(1→O)- at Thr-10, its non-glycosylated variant, and two glycopeptide analogs, one containing α--GalpNAc-(1→O)- at Thr-10 and the other containing β--Galp-(1→3)-α--GalpNAc-(1→O)- at Ser-7 [60].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}